C172H174FN21O25S6 — CID 158344931
[4-(cyclopentylmethyl)piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;ethyl 5-[4-[4-(quinolin-8-ylsulfonylmethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxylate;[4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(4-methoxyphenyl)methyl]piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-(4-methoxy-3-pyridinyl)piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;methyl 2-methoxy-5-[4-[4-(quinolin-8-ylsulfonylmethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxylate (PubChem CID 158344931) has the molecular formula C172H174FN21O25S6 and a molecular weight of 3146.81 g/mol. Its IUPAC name is [4-(cyclopentylmethyl)piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;ethyl 5-[4-[4-(quinolin-8-ylsulfonylmethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxylate;[4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(4-methoxyphenyl)methyl]piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-(4-methoxy-3-pyridinyl)piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;methyl 2-methoxy-5-[4-[4-(quinolin-8-ylsulfonylmethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxylate.
| Compound Name | [4-(cyclopentylmethyl)piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;ethyl 5-[4-[4-(quinolin-8-ylsulfonylmethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxylate;[4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(4-methoxyphenyl)methyl]piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-(4-methoxy-3-pyridinyl)piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;methyl 2-methoxy-5-[4-[4-(quinolin-8-ylsulfonylmethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxylate |
|---|---|
| PubChem CID | 158344931 |
| Molecular Formula | C172H174FN21O25S6 |
| Molecular Weight | 3146.81 g/mol |
| Exact Mass | 3144.13 |
| IUPAC Name | [4-(cyclopentylmethyl)piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;ethyl 5-[4-[4-(quinolin-8-ylsulfonylmethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxylate;[4-[(4-fluorophenyl)methyl]piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-[(4-methoxyphenyl)methyl]piperazin-1-yl]-[3-methyl-4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;[4-(4-methoxy-3-pyridinyl)piperazin-1-yl]-[4-(quinolin-8-ylsulfonylmethyl)phenyl]methanone;methyl 2-methoxy-5-[4-[4-(quinolin-8-ylsulfonylmethyl)benzoyl]piperazin-1-yl]pyridine-3-carboxylate |
| SMILES | CCOC(=O)c1cncc(N2CCN(C(=O)c3ccc(CS(=O)(=O)c4cccc5cccnc45)cc3)CC2)c1.COC(=O)c1cc(N2CCN(C(=O)c3ccc(CS(=O)(=O)c4cccc5cccnc45)cc3)CC2)cnc1OC.COc1ccc(CN2CCN(C(=O)c3ccc(CS(=O)(=O)c4cccc5cccnc45)c(C)c3)CC2)cc1.COc1ccncc1N1CCN(C(=O)c2ccc(CS(=O)(=O)c3cccc4cccnc34)cc2)CC1.Cc1cc(C(=O)N2CCN(CC3CCCC3)CC2)ccc1CS(=O)(=O)c1cccc2cccnc12.Cc1cc(C(=O)N2CCN(Cc3ccc(F)cc3)CC2)ccc1CS(=O)(=O)c1cccc2cccnc12 |
| InChI | InChI=1S/C30H31N3O4S.C29H28FN3O3S.C29H28N4O6S.C29H28N4O5S.C28H33N3O3S.C27H26N4O4S/c1-22-19-25(30(34)33-17-15-32(16-18-33)20-23-8-12-27(37-2)13-9-23)10-11-26(22)21-38(35,36)28-7-3-5-24-6-4-14-31-29(24)28;1-21-18-24(29(34)33-16-14-32(15-17-33)19-22-7-11-26(30)12-8-22)9-10-25(21)20-37(35,36)27-6-2-4-23-5-3-13-31-28(23)27;1-38-27-24(29(35)39-2)17-23(18-31-27)32-13-15-33(16-14-32)28(34)22-10-8-20(9-11-22)19-40(36,37)25-7-3-5-21-6-4-12-30-26(21)25;1-2-38-29(35)24-17-25(19-30-18-24)32-13-15-33(16-14-32)28(34)23-10-8-21(9-11-23)20-39(36,37)26-7-3-5-22-6-4-12-31-27(22)26;1-21-18-24(28(32)31-16-14-30(15-17-31)19-22-6-2-3-7-22)11-12-25(21)20-35(33,34)26-10-4-8-23-9-5-13-29-27(23)26;1-35-24-11-13-28-18-23(24)30-14-16-31(17-15-30)27(32)22-9-7-20(8-10-22)19-36(33,34)25-6-2-4-21-5-3-12-29-26(21)25/h3-14,19H,15-18,20-21H2,1-2H3;2-13,18H,14-17,19-20H2,1H3;3-12,17-18H,13-16,19H2,1-2H3;3-12,17-19H,2,13-16,20H2,1H3;4-5,8-13,18,22H,2-3,6-7,14-17,19-20H2,1H3;2-13,18H,14-17,19H2,1H3 |
| InChIKey | GRPOXGRDKXSIIP-UHFFFAOYSA-N |
| XLogP | 24.24 |
| TPSA | 542.44 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 39 |
| Heavy Atoms | 225 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3146.81 |
| LogP ≤ 5 | 24.24 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 40 |